Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
Adam P. Bress, Brandon K. Bellows, Jordan B. King, et al.
New England Journal of Medicine (2017) Vol. 377, Iss. 8, pp. 745-755
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Circulation (2019) Vol. 140, Iss. 11
Open Access | Times Cited: 4195
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Circulation (2019) Vol. 140, Iss. 11
Open Access | Times Cited: 3543
The global epidemiology of hypertension
Katherine T. Mills, Andrei Ştefănescu, Jiang He
Nature Reviews Nephrology (2020) Vol. 16, Iss. 4, pp. 223-237
Open Access | Times Cited: 2823
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura, Hisatomi Arima, Shuji Arima, et al.
Hypertension Research (2019) Vol. 42, Iss. 9, pp. 1235-1481
Open Access | Times Cited: 1536
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 10, pp. e177-e232
Open Access | Times Cited: 1490
The Global Burden of Cardiovascular Diseases and Risk
Muthiah Vaduganathan, George A. Mensah, Justine Varieur Turco, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 25, pp. 2361-2371
Open Access | Times Cited: 1135
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 10, pp. 1376-1414
Open Access | Times Cited: 1010
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
Alfred K. Cheung, Tara I. Chang, William C. Cushman, et al.
Kidney International (2021) Vol. 99, Iss. 3, pp. S1-S87
Open Access | Times Cited: 940
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Michael G. Shlipak, Sri Lekha Tummalapalli, L. Ebony Boulware, et al.
Kidney International (2020) Vol. 99, Iss. 1, pp. 34-47
Open Access | Times Cited: 369
A Community-Based Intervention for Managing Hypertension in Rural South Asia
Tazeen H. Jafar, Mihir Gandhi, H. Asita de Silva, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 8, pp. 717-726
Open Access | Times Cited: 206
On the utilization of polygenic risk scores for therapeutic targeting
Greg Gibson
PLoS Genetics (2019) Vol. 15, Iss. 4, pp. e1008060-e1008060
Open Access | Times Cited: 98
Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults
Joshua D. Bundy, Katherine T. Mills, Jing Chen, et al.
JAMA Cardiology (2018) Vol. 3, Iss. 7, pp. 572-572
Open Access | Times Cited: 92
Machine-learning-based high-benefit approach versus conventional high-risk approach in blood pressure management
Kosuke Inoue, Susan Athey, Yusuke Tsugawa
International Journal of Epidemiology (2023) Vol. 52, Iss. 4, pp. 1243-1256
Open Access | Times Cited: 30
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline
Ambarish Pandey, Kershaw V. Patel, Wanpen Vongpatanasin, et al.
Circulation (2019) Vol. 140, Iss. 25, pp. 2076-2088
Open Access | Times Cited: 59
The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study
Xu Chen, Liang Du, Ruiheng Wu, et al.
BMC Infectious Diseases (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 59
Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals
Brandon K. Bellows, Natalia Ruiz‐Negrón, Kirsten Bibbins‐Domingo, et al.
Circulation Cardiovascular Quality and Outcomes (2019) Vol. 12, Iss. 6
Open Access | Times Cited: 55
Medication Adherence and Associated Factors in Patients With Type 2 Diabetes: A Structural Equation Model
Jing Huang, Shenglan Ding, Shuyuan Xiong, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 48
Effectiveness and Cost-Effectiveness of Team-Based Care for Hypertension: A Meta-Analysis and Simulation Study
Kelsey B. Bryant, Aditi S Rao, Laura Cohen, et al.
Hypertension (2023) Vol. 80, Iss. 6, pp. 1199-1208
Closed Access | Times Cited: 17
Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
Francesca Lim, Brandon K. Bellows, Sarah Xinhui Tan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2329178-e2329178
Open Access | Times Cited: 17
Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline
Adam P. Bress, Lisandro D. Colantonio, Richard Cooper, et al.
Circulation (2018) Vol. 139, Iss. 1, pp. 24-36
Open Access | Times Cited: 50
Black–White Differences in Cardiovascular Disease Mortality: A Prospective US Study, 2003–2017
Gabriel S. Tajeu, Monika M. Safford, George Howard, et al.
American Journal of Public Health (2020) Vol. 110, Iss. 5, pp. 696-703
Open Access | Times Cited: 46
Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span
Muthiah Vaduganathan, Brian Claggett, Stephen P. Juraschek, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 5, pp. 576-576
Open Access | Times Cited: 40
Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops
Kelsey B. Bryant, Andrew E. Moran, Dhruv S. Kazi, et al.
Circulation (2021) Vol. 143, Iss. 24, pp. 2384-2394
Open Access | Times Cited: 38
Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease
Elodie Jacquelet, Aurélia Poujois, Marie‐Christine Pheulpin, et al.
Journal of Inherited Metabolic Disease (2021) Vol. 44, Iss. 6, pp. 1481-1488
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top